AZACITIDINE KABI POWDER FOR SUSPENSION FOR INJECTION 100 MG/VIAL
Product details
Registration number: SIN17378P
Classification: Prescription Only
Active ingredients: Azacitidine
Strength: 100.0 mg per vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route: SUBCUTANEOUS
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
ATC code: L01BC07
HSA approval date: 30 October 2025
Manufacturer(s): Fresenius Kabi Oncology Limited
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for AZACITIDINE KABI POWDER FOR SUSPENSION FOR INJECTION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17378P
Classification: Prescription Only
What active ingredients and strength are recorded for AZACITIDINE KABI POWDER FOR SUSPENSION FOR INJECTION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Azacitidine
Strength: 100.0 mg per vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for AZACITIDINE KABI POWDER FOR SUSPENSION FOR INJECTION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route: SUBCUTANEOUS
Who is the recorded registrant for AZACITIDINE KABI POWDER FOR SUSPENSION FOR INJECTION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for AZACITIDINE KABI POWDER FOR SUSPENSION FOR INJECTION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Fresenius Kabi Oncology Limited
Manufacturing country/countries: INDIA
Where can I look up AZACITIDINE KABI POWDER FOR SUSPENSION FOR INJECTION 100 MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17378P or the exact product name AZACITIDINE KABI POWDER FOR SUSPENSION FOR INJECTION 100 MG/VIAL. The general register link does not preselect this product.
What are the source dates for this AZACITIDINE KABI POWDER FOR SUSPENSION FOR INJECTION 100 MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this AZACITIDINE KABI POWDER FOR SUSPENSION FOR INJECTION 100 MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17378P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)